HELIOS Kliniken

Hospital


Location: diverse, Germany (DE) DE

ISNI: 0000000105499953

ROR: https://ror.org/04fjkxc67

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Choosing wisely Primarily the Quality of Indications (2016) Hasenfuss G, Maerker-Hermann E, Hallek M, Sieber C Journal article Do not intubate!? Management of acute respiratory failure in the elderly Do not intubate!? Management der akuten respiratorischen Insuffizienz bei alten Patienten (2016) Christ M, Esch E, Singler K, Heppner HJ Journal article, Review article Urosepsis in Geriatric Patients Urosepsis beim geriatrischen Patienten (2016) Yapan F, Wiedemann A, Heppner HJ Journal article, Review article Bioelectric navigation: A new paradigm for intravascular device guidance (2016) Fuerst B, Sutton EE, Ghotbi R, Cowan NJ, Navab N Conference contribution DISEASE PROGRESSION IN 282 PATIENTS WITH UNDIFFERENTIATED SSC - DATA FROM THE GERMAN NETWORK FOR SYSTEMIC SCLERODERMA (2016) Moinzadeh P, Blank N, Siegert E, Henes J, Susok L, Distler J, Juche A, et al. Conference contribution LOGIST - A local observational GIST registry: A non-interventional registry to observe patients with gastrointestinal stromal tumors (GIST) after R0/R1 resection - with or without adjuvant therapy with imatinib (CSTI571BDE77) - an interim analysis with 5 (2016) Reichardt P, Quietzsch D, Stuebs P, Cameron S, Gellert K, Wilhelm M, Killing B, et al. Conference contribution The Freiburg monosyllabic test put to the test (2016) Baljic I, Hoppe U Journal article Targeted Intraoperative Radiation Therapy Tumor Bed Boost During Breast-Conserving Surgery After Neoadjuvant Chemotherapy in TNBC and HER2 Positive Breast Cancer (2016) Kolberg HC, Loevey G, Akpolat-Basci L, Stephanou M, Fasching P, Untch M, Liedtke C, et al. Conference contribution Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: a biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial (2016) Janning M, Mueller , Vettorazzi E, Cubas-Cordova M, Gensch , Ben Batalla , Eulenburg ZC, et al. Conference contribution Tumor-infiltrating lymphocytes and response prediction to neoadjuvant chemotherapy in HER2-positive breast cancer (2016) Heppner BI, Untch M, Denkert C, Pfitzner BM, Lederer B, Schmidt W, Eidtmann H, et al. Conference contribution